CTOs on the Move

Kedrion

www.kedrion.com

 
Kedrion Biopharma develops and produces plasma-derived therapies, making them available to meet patients` needs the world over. We collect and fractionate blood plasma for the development, production and distribution of plasma derivatives used in the treatment of patients suffering from rare and chronic conditions such as hemophilia and immune system deficiencies. A corporation is not a person, but a corporation is run by people and it affects people. And Kedrion`s business is people. The very nature of our enterprise is to help people live more full and healthy lives. This commitment extends to how we conduct our business, that is, ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.kedrion.com
  • 400 Kelby St Fl 11
    Fort Lee, NJ USA 07024
  • Phone: 201.242.8900

Executives

Name Title Contact Details

Similar Companies

eMed

eMed offers you the first FDA-authorized, virtually guided, at-home COVID-19 rapid antigen test with automated results reporting.

Jewish Association On Aging

Jewish Association On Aging is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Secure Medical

Secure Medical is a Tempe, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Tech Group Subsidiary of West Pharmaceutical Services

The Tech Group, Inc Subsidiary of West Pharmaceutical Services, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. The Tech Group, Inc Subsidiary of West Pharmaceutical Services, Inc. is based in Scottsdale, AZ. You can find more information on The Tech Group, Inc Subsidiary of West Pharmaceutical Services, Inc. at www.techgroup.com

Repertoire

Repertoire Immune Medicines is working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions, and infectious diseases. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.